Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate.
about
Clinical Trials Corner: September 2017.Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.
P2860
Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Fifteen Years of Clinical Tria ...... Drug Development Success Rate.
@en
type
label
Fifteen Years of Clinical Tria ...... Drug Development Success Rate.
@en
prefLabel
Fifteen Years of Clinical Tria ...... Drug Development Success Rate.
@en
P2860
P50
P356
P1476
Fifteen Years of Clinical Tria ...... Drug Development Success Rate
@en
P2093
Joaquim J Ferreira
P2860
P304
P356
10.3233/JHD-170245
P577
2017-01-01T00:00:00Z